Pages

▼
Showing posts with label OTS. Show all posts
Showing posts with label OTS. Show all posts
Friday, June 27, 2014

ISIS Pharmaceutical Reveals Dynamic PolyConjugate Efforts

›
When Arrowhead Research made a splash 1 ½ years ago at the Boston OTS meeting in late October 2012 with impressive subQ DPC knockdown eff...
8 comments:
Sunday, October 27, 2013

OTS 2013 Meeting Report- Now Available

›
Want to learn how Oligonucleotide Therapeutics are emerging as the 3rd major drug discovery engine after small molecules and recombinant...
Monday, November 5, 2012

Bullish on RNAi Therapeutics

›
Attending the Oligonucleotide Therapeutics Society meeting last week in Boston, I could sense a new bullishness around RNAi Therapeutic...
4 comments:
Tuesday, September 13, 2011

Impressions from the Abstracts of the 7th Annual Meeting of the Oligonucleotide Therapeutics Society (Part 2)

›
The OTS Meeting has just finished and it looks like it was a success in that meaningful progress, especially on delivery, but also specific ...
1 comment:
Wednesday, September 7, 2011

Impressions from the Abstracts of the 7th Annual Meeting of the Oligonucleotide Therapeutics Society (Part 1)

›
The Annual Meetings of the Oligonucleotide Therapeutics Society are among the best on the conference circus related to, well, oligonucleotid...
Friday, October 5, 2007

Impressions from the 3rd Annual Meeting of the Oligonucleotide Therapeutics Society: Day 1

›
The 3rd Annual Meeting of the Oligonucleotide Society (OTS) got under way in the stylish Langenbeck-Virchow Auditorium situated in the centr...
2 comments: